Marc S Sabatine

46PUBLICATIONS

242CO-AUTHORS

Predictive and prognostic markersCardiovascular medicine and haematology not elsewhere classifiedCardiology (incl. cardiovascular diseases)Haematological tumoursMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (46)

Sort by Publication Date:

|Jun 03, 2026

Safety of low lipoprotein(a) levels: the FOURIER trial.

|May 29, 2026

Prior anticoagulation experience and bleeding risk with the factor XI inhibitor abelacimab in AZALEA-TIMI 71.

|May 25, 2026

Lipoprotein(a) Levels, Risk of Cardiovascular Events, and Benefit of Evolocumab: Findings From the VESALIUS-CV Trial.

|May 19, 2026

Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior Myocardial Infarction: Results From the VESALIUS-CV Trial.

|May 11, 2026

Early Versus Late Initiation of Evolocumab and Arterial Aneurysm Events: An Analysis of FOURIER and FOURIER-OLE.

|Mar 30, 2026

Effect of APOC3 Inhibition With Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study.

Nicholas A Marston, Brian A Bergmark, Thomas A Prohaska

Pageof 8

Frequent Collaborators

11 joint publications

Robert P Giugliano

11 joint publications

Michelle L O'Donoghue

10 joint publications

John J V McMurray

Stephen D Wiviott

Pardeep S Jhund

Sabina A Murphy

Brian A Bergmark

Lawrence A Leiter

Scott D Solomon

Mikhail N Kosiborod

Frequent Collaborators

11 joint publications

Robert P Giugliano

11 joint publications

Michelle L O'Donoghue

10 joint publications

John J V McMurray

8 joint publications

Stephen D Wiviott